News & Events

The value of our clients' news is directly related to the macro events and trends shaping the life sciences and healthcare industry. To appreciate one, you must fully understand the other.

Tiberend Strategic Advisors invites those interested in our firm and the companies we represent to access our News Feed and register for our Events Calendar.  Doing so, you will be assured to receive actionable information on the companies and trends that are defining the life sciences and healthcare space.

News Feed


Events Calendar

July 19 2018

Provention Bio Announces Closing of Upsized Initial Public Offering

July 17 2018

OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer


July 16 2018

OncoSec Appoints Sara M. Bonstein as Chief Financial Officer and Chief Operating Officer


July 9 2018

KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD

Apr 16 2018

OncoSec Provides Highlights from Research Reception at AACR Annual Meeting 2018


Apr 12 2018

ContraVir Pharmaceuticals Announces New Data Presented at the 2018 International Liver Congress™


Apr 9 2018

ContraVir Pharmaceuticals Appoints Two New Hepatitis B Experts to Scientific Advisory Board

Apr 5 2018

Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.


Apr 5 2018

TapImmune Provides Fourth Quarter and Year-End 2017 Corporate and Clinical Update


Apr 3 2018

Publication in Cephalalgia Indicates eNeura’s sTMS Significantly Reduces Migraine Frequency

Apr 3 2018

OncoSec to Host Research Reception During the 2018 American Association of Cancer Research Annual Meeting


Apr 2 2018

Cingulate Therapeutics Appoints Laurie Myers, PhD, MBA as Chief Operating Officer


Mar 29 2017

KemPharm Reports Fourth Quarter and Year End 2017 Results

Mar 28 2017

TapImmune to Present at The MicroCap Conference


Mar 27 2017

Rebiotix’s Lee Jones to Receive TRUST 2018 Courageous Women in Health Care Award


Mar 21 2017

KemPharm, Inc. to Report Fourth Quarter and Year End 2017 Results

Mar 20 2017

KemPharm Announces Positive Topline Results from KP415 Pharmacokinetic Study in Children and Adolescents With ADHD


Mar 20 2017

Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease


Mar 15 2017

Enteris BioPharma to Present at the 25th Annual Future Leaders in the Biotech Industry Conference

Mar 14 2017

Cantex to Present at Upcoming Investor Conferences

View more client news »